0001181431-11-059791.txt : 20111212 0001181431-11-059791.hdr.sgml : 20111212 20111212135041 ACCESSION NUMBER: 0001181431-11-059791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111208 FILED AS OF DATE: 20111212 DATE AS OF CHANGE: 20111212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGECKER PETER CENTRAL INDEX KEY: 0001282829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 111255774 MAIL ADDRESS: STREET 1: C/O INTARCIA THERAPEUTICS, INC. STREET 2: 2000 POWELL ST., SUITE 1640 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd327476.xml X0304 4 2011-12-08 0 0000908259 OXIGENE INC OXGN 0001282829 LANGECKER PETER C/O OXIGENE, INC. 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 1.03 2011-12-08 4 A 0 200000 0 A 2011-12-08 2021-12-08 Common Stock 200000 200000 D The Stock Option vests as follows: (1) 25% vested on the grant date (12/8/2011), and (2) the balance will vest monthly in twenty-four equal installments beginning one month following the grant date. /s/ Megan N. Gates, Attorney-in-fact 2011-12-12